KRAS and neoplasm: Similar effects were observed in a genetically engineered lung cancer mouse model within this study: simultaneous deletion of STAT3 and activation of oncogenic K-RAS in the lung epithelium resulted in increased tumor numbers, but ultimately reduced tumor growth/burden [123].